Ceritinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ceritinib. Educational only — not medical advice.
Labeled uses
ZYKADIA® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test [see Dosage and Administration (2.1)] .
Source: FDA labeling via NIH DailyMed (set fff5d805…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.